This is a Japan news story, published by MailOnline, that relates primarily to Faragher news.
For more Japan news, you can click here:
more Japan newsFor more Faragher news, you can click here:
more Faragher newsFor more biology news, you can click here:
more biology newsFor more news from MailOnline, you can click here:
more news from MailOnlineOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
cell ageing. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest older cells news, organismal ageing news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cell senescenceMailOnline
•Science
Science
76% Informative
Researchers from Osaka University , Japan claim to have found a cellular 'master switch' which can reverse the process of ageing.
This protein, called AP2A1, could be the key to future treatments that will undo the damage caused by old age.
As our bodies get older, we build up a growing number of 'senescent' cells which stop dividing and functioning as they should.
These 'zombie cells' don't die but rather continue to grow and pump out inflammatory chemicals which contribute to age-related diseases like Alzheimer's or arthritis.
Professor Faragher says that learning how to remove senescent cells from our bodies could 'transform health in later life' However, scientists caution that a 'cure' for ageing is still likely to be a long way off.
Dr Lazaros Foukas , a scientist researching ageing at University College London , told MailOnline : 'There are no sufficient data to supporting a potential therapeutic effect of interventions targeting AP2A1'.
VR Score
70
Informative language
67
Neutral language
21
Article tone
informal
Language
English
Language complexity
57
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
5
Source diversity
3
Affiliate links
no affiliate links
Small business owner?
